🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research is to assess the impact of cannabis on the ana...
Status
Completed
Location
New York State Psychiatric Institute
Start Date
2019-04-01
Trial ID
NCT03679949
The primary purpose of the study is to observe the adherence and health see...
Status
Completed
Location
Montefiore Medical Center
Start Date
2018-05-18
Trial ID
NCT03431363
Medical Marijuana is used widely, and its effects on the visual system and ...
Status
Unknown
Location
Hadassah Medical Center
Start Date
2018-09-01
Trial ID
NCT03078309
Treatments Being Tested
Chronic pain is a significant public health concern in the U.S., for which ...
Status
Completed
Location
New York State Psychiatric Institute
Start Date
2021-06-01
Trial ID
NCT04576507
Treatments Being Tested
This study will examine how discounted vouchers for medical cannabis use af...
Status
Completed
Location
Vireo Health of New York
Start Date
2020-10-06
Trial ID
NCT04495725
Treatments Being Tested
A study to assess the effects of Sativex treatment on spasticity in a popul...
Status
Completed
Location
Center 14
Start Date
2013-12
Trial ID
NCT01898520
The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Status
Completed
Location
Royal Berkshire Hospital
Start Date
2002-06
Trial ID
NCT00711646
This project is intended to evaluate self-emulsifying drug delivery system ...
Status
Completed
Location
Hadassah medical organization
Start Date
2013-08
Trial ID
NCT01893424
Treatments Being Tested
The proposed study is a double-blind, placebo-controlled, cross over study ...
Status
Completed
Location
PharmaHemp
Start Date
2020-10-15
Trial ID
NCT04634136
Chronic pain is a significant public health concern in the U.S., for which ...
Status
Suspended
Location
New York State Psychiatric Institute
Start Date
2021-08-01
Trial ID
NCT04596644
Treatments Being Tested